Human Complement C5 ELISA Kit

用户评价
货号-规格
价格
Qty.
CEA-B241-96tests
¥3120.00
合计0件 产品金额¥ 0

产品详情

  • 产品概述(Product Overview)

    Human Complement C5 ELISA Kit ELISA Kit is a ready-to-use immunoassay kit, specifically designed to quantify natural and recombinant human Complement C5 (not C5a) that is present in biological samples, such as human serum, plasma, and cell culture supernatants. Our ELISA Kit provides several benefits:

    1. Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M10 guideline.
    2. High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
    3. Simplified and straightforward protocols and ready-to-use reagents to save assay time.

  • 产品参数(Product Specifications)

    Assay Type
    Sandwich-ELISA
    Analyte
    Complement C5
    Format
    96-wells plate breakable into 12 x 8 wells strips
    Reactivity
    Human
    Sensitivity
    40 pg/mL
    Assay Time
    2.75 hr
    Sample volume
    50 μL
    Range
    78.125 pg/mL-5000 pg/mL
    Sample Type
    For the quantitative determination of human Complement C5 in serum, plasma and cell supernatant.

    Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.

  • 应用说明(Application)

    The kit is developed for quantitative detection of human complement C5 in serum, plasma and cell culture supernates.

    It is for research use only.

  • 流程图(Workflow)

    Complement C5 Workflow

  • 存储(Storage)

    Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • 组分(Materials Provided)

    ID
    Components
    Size
    CEA241-C01
    Pre-coated Anti-Complement C5 Antibody Microplate
    1 plate
    CEA241-C02
    Human Complement C5 Standard
    1 μg×2
    CEA241-C03
    Biotin-Anti-Complement C5 Antibody Con. Solution
    100 μL
    CEA241-C04
    Biotin-Antibody Dilution Buffer
    8 mL
    CEA241-C05
    Streptavidin-HRP Con. Solution
    500 μL
    CEA241-C06
    Streptavidin-HRP Dilution Buffer
    15 mL
    CEA241-C07
    20× Washing Buffer
    50 mL
    CEA241-C08
    Sample Dilution Buffer
    15 mL×2
    CEA241-C09
    Substrate Solution
    12 mL
    CEA241-C10
    Stop Solution
    6 mL
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

推荐产品

数据展示

  • 典型数据-Typical Data

    Please refer to DS document for the assay protocol.

     Complement C5 TYPICAL DATA

    For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was calculated based on the results of the standard curve. The minimum detectable concentration of Complement C5 is less than 40 pg/mL.

验证
  • 样本值(Sample Values)

    Twenty-four healthy serum samples were evaluated for the concentrations of human Complement C5 in assay.

     Complement C5 SAMPLE VALUES
  • 批内差异(Intra-Assay Statistics)

    Ten replicates of each of three samples containing different Complement C5 concentrations were tested in one assay. Acceptable criteria: CV<10%.

     Complement C5 INTRA-ASSAY STATISTICS
  • 批间差异(Inter-Assay Statistics)

    Three samples containing different concentrations of Complement C5 were tested in independent assays. Acceptable criteria: CV<15%.

     Complement C5 INTER-ASSAY STATISTICS
  • 回收率(Recovery)

    Recombinant Complement C5 was spiked into three diluted human serum samples, and then analyzed. The average recovery of Complement C5 for serum samples is 97.4%.

     Complement C5 RECOVERY

用户评价
发表评论

前沿进展

 
药物研发进展
  • 英文全称:

    Complement C5

  • 中文全称:

    补体C5

  • 种类:

  • 上市药物数量:

    8 详情

  • 临床药物数量:

    18 详情

  • 最高研发阶段:

    批准上市

联系我们
项目合作
查看更多项目
实验案例分析
查看更多案例分析
  • 产品基础信息
  • 产品详情
  • 推荐产品
  • 数据展示
  • 用户评价